Welcome to our dedicated page for Dassault Systemes news (Ticker: DASTY), a resource for investors and traders seeking the latest updates and insights on Dassault Systemes stock.
DASSAULT SYSTEMES SA ADR (DASTY) news on Stock Titan reflects the official communications of Dassault Systèmes, a software publisher in the information sector whose underlying shares trade on Euronext Paris as DSY.PA. The company’s releases provide insight into its 3DEXPERIENCE platform, virtual worlds strategy and AI-embedded software offerings, as well as its capital markets activity.
Investors following DASTY can use this page to review earnings and financial updates, where Dassault Systèmes reports quarterly and year-to-date revenue, software revenue, recurring revenue, operating margin and diluted earnings per share under IFRS and non-IFRS measures. These announcements also break down software revenue by geography, product line and industry, and highlight the contribution of areas such as Industrial Innovation, Life Sciences and Mainstream Innovation.
The news feed also includes corporate and strategic announcements, such as information about Medidata, a Dassault Systèmes brand that provides clinical trial solutions. Releases describe Medidata Patient, Data and Study Experiences and collaborations with life sciences companies like Sanofi, emphasizing goals such as streamlining clinical workflows, enhancing data quality and accelerating the development of new therapies.
In addition, Dassault Systèmes publishes regulatory and capital markets disclosures, including declarations of the number of outstanding shares and voting rights, reports on trading in its own shares under repurchase programs, and half-year statements on its liquidity contract. Bookmark this page to access a consolidated view of these official updates related to DASTY and the underlying Dassault Systèmes shares.
Dassault Systèmes announced the total number of its outstanding shares and voting rights as of July 31, 2022. The company reported 1,334,109,839 outstanding shares and 2,000,082,728 voting rights. The voting rights are calculated based on the total number of outstanding shares, including those with suspended rights. Shareholders are reminded to refer to Article 223-11 of the Autorité des marchés financiers for details on declaring threshold crossings. The company serves over 300,000 customers globally, promoting sustainable innovation.
Dassault Systèmes announced the filing of its 2022 Half-Year Financial Report as of June 30, 2022, in compliance with IFRS standards. This report is publicly available for review and includes consolidated financial statements. Investors can access the report on Dassault Systèmes’ website. Hard copies can be requested at their headquarters in France. The company supports over 300,000 customers globally, emphasizing its role in providing collaborative 3D environments for sustainable innovation.
Dassault Systèmes reported strong second-quarter results, with total revenue rising 11% year-over-year to €1.38 billion. Software revenue also increased 11%, attributed to robust subscription revenue growth of 10% and a 14% increase in licenses. Non-IFRS diluted EPS grew 21% to €0.26, exceeding expectations, though IFRS diluted EPS fell 32% to €0.09 due to a one-time tax dispute charge. The company is reaffirming its full-year revenue growth target of 9%-10% and raising its diluted EPS target to €1.08-€1.10. Strong performance across geographies and product lines signals resilience amidst macroeconomic challenges.
On July 13, 2022, Dassault Systèmes reported its half-year statement on the liquidity contract with Oddo BHF SCA. As of June 30, 2022, the liquidity account held 519,175 shares and €13,616,230.41 in cash. Initially, the contract started with zero shares and €10,000,000 in cash. Over the years, contributions increased the cash to €20,000,000. From January 1 to June 30, 2022, there were 3,066 purchases and 1,725 sales, totaling 637,750 shares traded.
Dassault Systèmes reported the number of outstanding shares and voting rights as of June 30, 2022. The total number of outstanding shares stands at 1,333,800,851, while the total number of voting rights is 1,999,807,399. This data complies with the regulations set by the Autorité des marchés financiers. The calculation of voting rights includes shares with suspended voting rights, as intended by the regulatory framework. Shareholders are encouraged to declare crossing of thresholds to the company's Investor Relations.
Dassault Systèmes has disclosed its share repurchase activities from June 14 to June 17, 2022. The program, authorized by the General Meeting on May 19, 2022, involves purchasing ordinary shares to enhance shareholder value. Notably, the company acquired a total of 270,000 shares at an average price of €33.98 on June 14, 2022. The trades were executed across multiple markets including XPAR and DXE, with significant volumes reported on different days. For detailed transaction information, visit Dassault Systèmes' investor relations page.
eClinical Solutions is enhancing its role in the life sciences sector by participating in the DIA 2022 Global Annual Meeting in Chicago, where Katrina Rice will present on the evolution of clinical data roles. The session, titled 'Transformation of the Data Manager to the Data Scientist,' will focus on digitally-enabled processes to improve clinical trials. The company will also showcase advancements in its elluminate Clinical Data Cloud, aimed at streamlining data management and enhancing trial efficiency.
Dassault Systèmes announced a share repurchase program initiated by the General Meeting of Shareholders on May 19, 2022. The disclosure covers trading details for June 10, 2022, with a total of 162,000 shares acquired at an average price of €37.4235. Additional transactions accounted for 80,000 and 8,000 shares at average prices of €37.3774 and €37.4048, respectively. This buyback initiative aims to enhance shareholder value and reflects the company's commitment to returning capital to investors.
Dassault Systèmes held its 2022 Capital Markets Day on June 16, 2022, outlining its trajectory to achieve non-IFRS EPS objectives of €1.20 by 2024. Executive management emphasized the company’s strong position in the market, projecting growth across manufacturing, life sciences, and infrastructure sectors. The integration of Medidata diversifies opportunities, addressing a market potential of €100 billion. The firm reported a high cash conversion rate, achieving its deleveraging target ahead of schedule, ensuring financial flexibility for strategic priorities.
Dassault Systèmes disclosed its share repurchase activity for the period from June 1 to June 8, 2022. The program, approved at the General Meeting of Shareholders on May 19, 2022, involved trading in ordinary shares. On June 1 alone, 122,500 shares were bought at an average price of €38.9450. The company reported daily trading volumes and acquisition prices, indicating ongoing commitment to shareholder value. Detailed transaction information is available on their website.